ABEO - H chart formed a bullish hrmonic pattern called BAT so BUY around 2.30 to 2.10 T1 2.75 T2 3.13 SL closing below 1.90
According to its website, it is a fully-integrated gene and cell therapy company at the forefront of the rapidly-advancing field of genetic medicine. Our expertise across R&D, manufacture, and discovery of novel gene and cell therapies has us uniquely positioned to bring new medicines to patients in need.
One swing crossed SMA50 and SMA200 trendline break and re-test Entry 2.75 no Stop Target 5 I am not a PRO trader. I trade option to test my trading plan with small cost. The max Risk of each plan is less than 1% of my account. If you like this idea, please use SIM/Demo account to try it.
Why get subbed to me on Tradingview? -TOP author on TradingView -15+ years experience in markets -Professional chart break downs -Supply/Demand Zones -TD9 counts / combo review -Key S/R levels -No junk on my charts -Frequent updates -Covering FX/crypto/US stocks -24/7 uptime so constant updates ABEO W1: BEST Level to BUY/HOLD 200%+...
2.62 Pre market price, do you think we can take profit on monday?
Buy in the range of 1,46-1,56 with a stop loss of 0,99 and the targets as resistance line to scale out of your position.
NASDAQ:ABEO I hope you enjoy this video. Key Takeaways ----------------- Important Gann Levels broken (Bullish) Double Bottomed (Bullish) Gap to Fill (Bullish) Indicators Have Plenty of Room To Run Lots of Volume Showing Accumulation (Bullish) Short Term Consolidation and downward movement to mid 1.5s is possible To Fulfill the Falling wedge pattern, Which...
ENJOY. This one is going to grow a lot. Target price: 4.5 USD
statistically, looking for anything between $2.5 and $3 Currently 1% of the portfolio @$1.48 and looking to add Tomorrow, hoping to catch it under $1.70. Aiming to bring the position to 10% of the portfolio for a little while.
- DOUBLE BOTTOM IN - EARNINGS SURPRISE - $14MIL IN LICENCING DEALS, - POSSIBLE $112MIL IN CONTINUED DEVELOPMENT AND ROYALTIES WITH TAYSHA - LOW RISK, HIGH RETURN - TARGET RANGE $3.3 - POSSBILE LONG HOLD FOR FURTHER GAINS. COMPANY WELL DISCOUNTED AT THE MOMENT
Wolfe Wave has 100% left to EPA. breaking the channel resistance now, buy pullbacks
LETSSSSSSSSSSGO Broadening wedge all time chart, double bottom 3M chart? Sounds like a LONGGGG hold to me.. Targets $4.32 , $9 .. well and even $18
Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo...
Looks like it might drop more and test 2.17, if that fail, we could be looking at 1.80s - hit my SL, currently no position.